Company intelligence / Profile preview
JMB
Princeton, New Jersey, United Statesjmbpharma.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
JMB is a biotechnology company focused on the development of novel monoclonal antibodies for the treatment of cancer and other serious diseases. The company leverages its expertise in antibody engineering to target key pathways involved in tumor growth and angiogenesis, such as the VEGF and EGFR signaling cascades. JMB's research and development efforts are primarily centered on creating high-affinity therapeutic candidates that can provide improved efficacy and safety profiles compared to existing treatments. Based in the United States, the company operates as a private entity, advancing its pipeline through internal research and strategic collaborations within the life sciences sector.
- Therapeutic areas
- Oncology
- Modalities
- Monoclonal antibodyAntibody
- Industry
- Biotech
02
Drug pipeline
1 assetBeyond the preview
Go deeper on JMB.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on JMB.